We found 184 records for "Drug safety / pharmacovigilance"

Articles

Does real world evidence matter in Health Technology Assessments?

27th January 2015

 Does real world evidence matter in Health Technology Assessments?Articles

Health Technology Assessment (HTA) agencies usually rely on randomised controlled trials for clinical data when evaluating drugs, but these do not always tell the entire story. Both biopharmaceutical companies and...

Read more

Ethics and the public good: the race to find a treatment for Ebola

20th January 2015

 Ethics and the public good: the race to find a treatment for EbolaArticles

With world attention focused on the Ebola outbreak, debate continues about whether experimental treatments should be given to patients when no other option exists. Leanne Orchard examines the implications of...

Read more

Broadening the RWD conversation

26th November 2014

 Broadening the RWD conversationArticles

There can be few pharma CEOs who are not acutely aware of the data revolution exploding around them and the need to enhance their data analytics capabilities. But technical expertise...

Read more

Global clinical trials: be aware of the pitfalls

8th October 2014

 Global clinical trials: be aware of the pitfallsArticles

Though there are many benefits to conducting clinical trials in countries outside the US and Europe, there are also cultural and linguistic challenges to consider.The globalisation of clinical studies is...

Read more

News

Experimental Ebola blood therapy trial gets under way

15th December 2014

 Experimental Ebola blood therapy trial gets under wayNews

Blood taken from survivors of Ebola could help protect others who contract the deadly disease, as part of a new trial in Liberia.The Ebola convalescent plasma (ECP) clinical trial will...

Read more

Positive early results for GSK/NIAID Ebola vaccine

27th November 2014

 Positive early results for GSK/NIAID Ebola vaccineNews

A phase I trial on an experimental vaccine to prevent Ebola virus disease show it was well-tolerated and produced immune system responses in all 20 healthy adults who received it.Co-developed...

Read more

EFPIA hails joint action on counterfeit drugs

15th September 2014

 EFPIA hails joint action on counterfeit drugsNews

The European Federation of Pharmaceutical Industries and Associations (EFPIA) is backing the European Stakeholder Model (ESM) as a means to combat the resale of stolen and counterfeit drugs in the...

Read more

Smartphones and social media to gather drug safety data

5th September 2014

 Smartphones and social media to gather drug safety dataNews

Smartphones, apps and social media will be used in a European drive to find new ways of gathering information on suspected adverse drug reactions.The UK's medicines regulator the Medicines and...

Read more

White Papers

Diabetes in France

23rd July 2014

 Diabetes in FranceWhite Papers

Analysis of open social media in relation to a particular disease area can provide useful intelligence on how different treatments and pharmaceutical companies are perceived, by both doctors and patients,...

Read more

Diabetes in Germany

16th July 2014

 Diabetes in GermanyWhite Papers

Analysis of open social media in relation to a particular disease area can provide useful intelligence on how different treatments and pharmaceutical companies are perceived, by both doctors and patients,...

Read more

Diabetes in the UK

9th July 2014

 Diabetes in the UKWhite Papers

Analysis of open social media in relation to a particular disease area can provide useful intelligence on how different treatments and pharmaceutical companies are perceived, by both doctors and patients,...

Read more

Understanding the psychological blocks in medicine-taking: how pharma can help

17th June 2014

 Understanding the psychological blocks in medicine-taking: how pharma can helpWhite Papers

Medicines adherence remains a massive problem for healthcare systems, the pharmaceutical industry and patients, leading to increased disease burden and personal risks. In this new white paper, Hannah Gagen looks...

Read more

Audio & Video

Full round table: Oncology shaping the future of personalised healthcare

  Watch the full round table video debate on 'oncology shaping the future of personalised healthcare', to see what our expert panel, with representation from pharma, diagnostics, physicians and patients, think...

Read more

Part four: Oncology shaping the future of personalised healthcare

  In the final section of our video round table on personalised healthcare in oncology, the expert panel reviews where this space is heading, how lessons learned can apply beyond cancer...

Read more

Events

The Biologics Congress

2nd February 2015 - 3rd February 2015

The Biologics Congress

The Biologics market is evolving with the development of new products and therapies and is expected to hit $200 billion in the next few years. With growing commercial potential, good...

Read more

Parallel Trade

9th February 2015

Parallel Trade

Different regulatory regimes for pharmaceuticals result in significant differences in pharmaceutical prices across countries. These prices make it profitable for parallel trade to take place in addition to it reaching...

Read more

Pharmaceutical Strategic Patient Access and Support Conference

9th February 2015

Pharmaceutical Strategic Patient Access and Support Conference

Examine the ever-changing patient access landscape as coverage guidelines and determinations continue to evolve, with thorough discussion of topics including formulary placement, utilizing EMRS and ERX, quality reporting criteria, and...

Read more

RNA Therapeutics

16th February 2015 - 17th February 2015

RNA Therapeutics

RNA Therapeutics 2015 returns to London on 16th and 17th February, gathering a room full of scientific pioneers and industry experts to identify the latest advancements, best practice and strategies...

Read more

Press Releases

New Schoonveld book is now available!

10th December 2014

New Schoonveld book is now available!

It's here!   The eagerly awaited new editon of THE PRICE OF GLOBAL HEALTH  is now available.   Written by global drug pricing expert Ed Schoonveld, The Price of Global Health (second edition) is...

Read more

Ashfield Commercial & Medical Services redefines healthcare outsourcing to meet pharma's challenges

5th February 2014

Ashfield Commercial & Medical Services redefines healthcare outsourcing to meet pharma's challenges

  Ashfield Commercial & Medical Services   redefines healthcare outsourcing to meet pharma’s challenges   03 February 2014: UDG Healthcare plc (formerly United Drug plc), a leading international provider of services to healthcare manufacturers...

Read more

Datatrial Presented with Prestigious Award at SCDM Annual Conference

2nd October 2013

Datatrial Presented with Prestigious Award at SCDM Annual Conference

Efficient CDM Process Earns Boutique Data Management Company a Data Driven Innovation Award Chicago, October 2, 2013—At the Society for Clinical Data Management (SCDM) annual meeting, Datatrial was among three companies...

Read more

Unique round table debate brings together key personalised healthcare stakeholders

1st October 2013

Unique round table debate brings together key personalised healthcare stakeholders

AstraZeneca and pharmaphorum media today announced the publication of a unique piece of thought leadership research, via a video round table debate entitled ‘Oncology shaping the future of personalised healthcare’,...

Read more